title: [Current status and perspective of vasculitis in Japan].
authors.forename: Ken-Ei
authors.initials: KE
authors.lastname: Sada
authors.forename: Hirofumi
authors.initials: H
authors.lastname: Makino
mesh_terms: D056648:Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / Q000145:classification / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D044466:Asian People; D015331:Cohort Studies; D003520:Cyclophosphamide / Q000008:administration & dosage; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007564:Japan / Q000453:epidemiology; D010951:Plasma Exchange; D011239:Prednisolone / Q000008:administration & dosage; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012074:Remission Induction; D006435:Renal Dialysis; D012189:Retrospective Studies; D000069283:Rituximab; D012720:Severity of Illness Index
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab; D003520:Cyclophosphamide; D011239:Prednisolone